Major histocompatibility complex class I binding predictions as a tool in epitope discovery

Publication: Research - peer-reviewJournal article – Annual report year: 2010

View graph of relations

Over the last decade, in silico models of the major histocompatibility complex (MHC) class I pathway have developed significantly. Before, peptide binding could only be reliably modelled for a few major human or mouse histocompatibility molecules; now, high-accuracy predictions are available for any human leucocyte antigen (HLA) -A or -B molecule with known protein sequence. Furthermore, peptide binding to MHC molecules from several non-human primates, mouse strains and other mammals can now be predicted. In this review, a number of different prediction methods are briefly explained, highlighting the most useful and historically important. Selected case stories, where these 'reverse immunology' systems have been used in actual epitope discovery, are briefly reviewed. We conclude that this new generation of epitope discovery systems has become a highly efficient tool for epitope discovery, and recommend that the less accurate prediction systems of the past be abandoned, as these are obsolete.
Original languageEnglish
JournalImmunology
Publication date2010
Volume130
Issue3
Pages309-318
ISSN0019-2805
DOIs
StatePublished
CitationsWeb of Science® Times Cited: 30

Keywords

  • epitope prediction, cytotoxic T lymphocytes, human leucocyte antigen, major histocompatibility complex class I, major histocompatibility complex-peptide binding
Download as:
Download as PDF
Select render style:
APAAuthorCBEHarvardMLAStandardVancouverShortLong
PDF
Download as HTML
Select render style:
APAAuthorCBEHarvardMLAStandardVancouverShortLong
HTML
Download as Word
Select render style:
APAAuthorCBEHarvardMLAStandardVancouverShortLong
Word

ID: 5132601